178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
OCTAVE study reveals vaccine responses in patients with impaired immune systems

OCTAVE study reveals vaccine responses in patients with impaired immune systems

by University of GlasgowCredit: Pixabay/CC0 Public DomainThe OCTAVE study—a multi-center, UK-wide trial, led by the University of Glasgow and co-ordinated by the University of Birmingham's Ca

OCTAVE study reveals vaccine responses in patients with impaired immune systems

by University of GlasgowCredit: Pixabay/CC0 Public DomainThe OCTAVE study—a multi-center, UK-wide trial, led by the University of Glasgow and co-ordinated by the University of Birmingham's Ca
Early-life exposure to famine linked to increased odds of RA

Early-life exposure to famine linked to increased odds of RA

(HealthDay)—Individuals exposed to famine in utero or in early childhood have an increased likelihood of developing rheumatoid arthritis (RA) in adulthood, according to a study published in the April

Early-life exposure to famine linked to increased odds of RA

(HealthDay)—Individuals exposed to famine in utero or in early childhood have an increased likelihood of developing rheumatoid arthritis (RA) in adulthood, according to a study published in the April
Patients with rheumatic and musculoskeletal conditions vulnerable to long term opioid use

Patients with rheumatic and musculoskeletal conditions vulnerable to long term opioid use

by British Medical JournalCredit: Unsplash/CC0 Public DomainPatients with rheumatic and musculoskeletal conditions are vulnerable to long term opioid use, with up to 1 in 3 of those with rheumato

Patients with rheumatic and musculoskeletal conditions vulnerable to long term opioid use

by British Medical JournalCredit: Unsplash/CC0 Public DomainPatients with rheumatic and musculoskeletal conditions are vulnerable to long term opioid use, with up to 1 in 3 of those with rheumato
Abatacept therapy offers promising results for treating juvenile dermatomyositis

Abatacept therapy offers promising results for treating juvenile dermatomyositis

by George Washington UniversityScreening, Trial Entry and Outcome. Credit:Arthritis & Rheumatology(2023). DOI: 10.1002/art.42450Juvenile dermatomyositis, a rare but often severe a

Abatacept therapy offers promising results for treating juvenile dermatomyositis

by George Washington UniversityScreening, Trial Entry and Outcome. Credit:Arthritis & Rheumatology(2023). DOI: 10.1002/art.42450Juvenile dermatomyositis, a rare but often severe a
Dupilumab cuts exacerbations in late-onset asthma

Dupilumab cuts exacerbations in late-onset asthma

(HealthDay)—Dupilumab is associated with significantly reduced severe exacerbation rates in patients with late-onset asthma with or without fixed airway obstruction, according to a study presented at

Dupilumab cuts exacerbations in late-onset asthma

(HealthDay)—Dupilumab is associated with significantly reduced severe exacerbation rates in patients with late-onset asthma with or without fixed airway obstruction, according to a study presented at
Study finds antibody-associated vasculitis characteristics and treatments vary across lifespan

Study finds antibody-associated vasculitis characteristics and treatments vary across lifespan

by American College of RheumatologyMedications ever received by patients with granulomatosis with polyangiitis and microscopic polyangiitis stratified by age at diagnosis. Credit: The Association

Study finds antibody-associated vasculitis characteristics and treatments vary across lifespan

by American College of RheumatologyMedications ever received by patients with granulomatosis with polyangiitis and microscopic polyangiitis stratified by age at diagnosis. Credit: The Association
Study finds COVID-19 vaccine not associated with severe disease flare in patients with rheumatic diseases

Study finds COVID-19 vaccine not associated with severe disease flare in patients with rheumatic diseases

by American College of RheumatologyCredit: Unsplash/CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that the

Study finds COVID-19 vaccine not associated with severe disease flare in patients with rheumatic diseases

by American College of RheumatologyCredit: Unsplash/CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that the
HSPC-derived CAR T-cells capable of lasting engraftment

HSPC-derived CAR T-cells capable of lasting engraftment

(HealthDay)—Hematopoietic stem/progenitor cell (HSPC)-derived chimeric antigen receptor (CAR) T-cells are capable of long-term engraftment in a model of HIV/AIDS, according to a study published online

HSPC-derived CAR T-cells capable of lasting engraftment

(HealthDay)—Hematopoietic stem/progenitor cell (HSPC)-derived chimeric antigen receptor (CAR) T-cells are capable of long-term engraftment in a model of HIV/AIDS, according to a study published online
Chromosomal loop signatures could identify poor drug response in arthritis

Chromosomal loop signatures could identify poor drug response in arthritis

by University of GlasgowCredit: University of GlasgowChromosomal loop signatures found in blood samples obtained in early rheumatoid arthritis could identify patients that will not respond adequa

Chromosomal loop signatures could identify poor drug response in arthritis

by University of GlasgowCredit: University of GlasgowChromosomal loop signatures found in blood samples obtained in early rheumatoid arthritis could identify patients that will not respond adequa
COVID infection may boost antibodies for up to 20 months

COVID infection may boost antibodies for up to 20 months

If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.While this is reassuring, experts are quick to caution that the new findings don't n

COVID infection may boost antibodies for up to 20 months

If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.While this is reassuring, experts are quick to caution that the new findings don't n
Fatigue among arthritis sufferers relieved by physical activity and talking therapies

Fatigue among arthritis sufferers relieved by physical activity and talking therapies

by University of AberdeenPrimary outcomes across follow-up points. Error bars show SD. CFS=Chalder Fatigue Scale. FSS=Fatigue Severity Scale. PEP=personalized exercise programs. CBA=cognitive beh

Fatigue among arthritis sufferers relieved by physical activity and talking therapies

by University of AberdeenPrimary outcomes across follow-up points. Error bars show SD. CFS=Chalder Fatigue Scale. FSS=Fatigue Severity Scale. PEP=personalized exercise programs. CBA=cognitive beh
Chip identifies rhinoviruses as cause of asthma

Chip identifies rhinoviruses as cause of asthma

by Medical University of ViennaCredit: Medical University of ViennaMedUni Vienna has developed a method that can be used to identify individual rhinovirus strains ("cold viruses") as a

Chip identifies rhinoviruses as cause of asthma

by Medical University of ViennaCredit: Medical University of ViennaMedUni Vienna has developed a method that can be used to identify individual rhinovirus strains ("cold viruses") as a